The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

The Future of Immune Checkpoint Inhibition in Gastric and Esophageal Cancers

Geoffrey Y. Ku, MD
Published Online:3:19 PM, Thu February 2, 2017

Geoffrey Y. Ku, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the future of immune checkpoint inhibition in gastric and esophageal cancers.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.